140 related articles for article (PubMed ID: 8039598)
1. High glucose concentration causes a decrease in mesangium degradation. A factor in the pathogenesis of diabetic nephropathy.
McLennan SV; Fisher EJ; Yue DK; Turtle JR
Diabetes; 1994 Aug; 43(8):1041-5. PubMed ID: 8039598
[TBL] [Abstract][Full Text] [Related]
2. The glomerular mesangium in diabetes mellitus.
Kreisberg JI; Ayo SH
Kidney Int; 1993 Jan; 43(1):109-13. PubMed ID: 8433549
[TBL] [Abstract][Full Text] [Related]
3. Effect of glucose on matrix metalloproteinase activity in mesangial cells.
McLennan SV; Yue DK; Turtle JR
Nephron; 1998; 79(3):293-8. PubMed ID: 9678429
[TBL] [Abstract][Full Text] [Related]
4. High glucose reduces generation of plasmin activity by mesangial cells.
Fisher EJ; McLennan SV; Yue DK; Turtle JR
Microvasc Res; 1997 Mar; 53(2):173-8. PubMed ID: 9143550
[TBL] [Abstract][Full Text] [Related]
5. Connective tissue growth factor mediates high glucose effects on matrix degradation through tissue inhibitor of matrix metalloproteinase type 1: implications for diabetic nephropathy.
McLennan SV; Wang XY; Moreno V; Yue DK; Twigg SM
Endocrinology; 2004 Dec; 145(12):5646-55. PubMed ID: 15345671
[TBL] [Abstract][Full Text] [Related]
6. Role of protein kinase C-angiotensin II pathway for extracellular matrix production in cultured human mesangial cells exposed to high glucose levels.
Ikehara K; Tada H; Kuboki K; Inokuchi T
Diabetes Res Clin Pract; 2003 Jan; 59(1):25-30. PubMed ID: 12482638
[TBL] [Abstract][Full Text] [Related]
7. Effects of mesangium glycation on matrix metalloproteinase activities: possible role in diabetic nephropathy.
McLennan SV; Martell SK; Yue DK
Diabetes; 2002 Aug; 51(8):2612-8. PubMed ID: 12145178
[TBL] [Abstract][Full Text] [Related]
8. High glucose inhibits nitric oxide production in cultured rat mesangial cells.
Trachtman H; Futterweit S; Crimmins DL
J Am Soc Nephrol; 1997 Aug; 8(8):1276-82. PubMed ID: 9259354
[TBL] [Abstract][Full Text] [Related]
9. BMK1 is activated in glomeruli of diabetic rats and in mesangial cells by high glucose conditions.
Suzaki Y; Yoshizumi M; Kagami S; Nishiyama A; Ozawa Y; Kyaw M; Izawa Y; Kanematsu Y; Tsuchiya K; Tamaki T
Kidney Int; 2004 May; 65(5):1749-60. PubMed ID: 15086914
[TBL] [Abstract][Full Text] [Related]
10. Induction of nodular sclerosis by insulin in rat mesangial cells in vitro: studies of collagen.
Abrass CK; Spicer D; Raugi GJ
Kidney Int; 1995 Jan; 47(1):25-37. PubMed ID: 7731154
[TBL] [Abstract][Full Text] [Related]
11. Role of angiotensin II in glucose-induced inhibition of mesangial matrix degradation.
Singh R; Alavi N; Singh AK; Leehey DJ
Diabetes; 1999 Oct; 48(10):2066-73. PubMed ID: 10512375
[TBL] [Abstract][Full Text] [Related]
12. Reduction of leucocyte proteolytic enzyme activity in diabetic patients with microalbuminuria and proteinuria: its possible role in diabetic nephropathy.
McLennan SV; Zilkens RR; Yue DK; Turtle JR
Diabet Med; 1996 Feb; 13(2):145-9. PubMed ID: 8641119
[TBL] [Abstract][Full Text] [Related]
13. High glucose increases inducible NO production in cultured rat mesangial cells. Possible role in fibronectin production.
Noh H; Ha H; Yu MR; Kang SW; Choi KH; Han DS; Lee HY
Nephron; 2002 Jan; 90(1):78-85. PubMed ID: 11744809
[TBL] [Abstract][Full Text] [Related]
14. Growth factor midkine is involved in the pathogenesis of diabetic nephropathy.
Kosugi T; Yuzawa Y; Sato W; Kawai H; Matsuo S; Takei Y; Muramatsu T; Kadomatsu K
Am J Pathol; 2006 Jan; 168(1):9-19. PubMed ID: 16400005
[TBL] [Abstract][Full Text] [Related]
15. Protein kinase C in diabetic nephropathy.
Craven PA; Studer RK; Negrete H; DeRubertis FR
J Diabetes Complications; 1995; 9(4):241-5. PubMed ID: 8573737
[TBL] [Abstract][Full Text] [Related]
16. Increased extracellular matrix synthesis and mRNA in mesangial cells grown in high-glucose medium.
Ayo SH; Radnik RA; Glass WF; Garoni JA; Rampt ER; Appling DR; Kreisberg JI
Am J Physiol; 1991 Feb; 260(2 Pt 2):F185-91. PubMed ID: 1996670
[TBL] [Abstract][Full Text] [Related]
17. High glucose causes an increase in extracellular matrix proteins in cultured mesangial cells.
Ayo SH; Radnik RA; Garoni JA; Glass WF; Kreisberg JI
Am J Pathol; 1990 Jun; 136(6):1339-48. PubMed ID: 2356864
[TBL] [Abstract][Full Text] [Related]
18. Vascular factors altered in glucose-treated mesangial cells and diabetic glomeruli. Changes in vascular factors impair endothelial cell growth and matrix.
Singh AK; Gudehithlu KP; Pegoraro AA; Singh GK; Basheerudin K; Robey RB; Arruda JA; Dunea G
Lab Invest; 2004 May; 84(5):597-606. PubMed ID: 15048134
[TBL] [Abstract][Full Text] [Related]
19. High glucose-induced intercellular adhesion molecule-1 (ICAM-1) expression through an osmotic effect in rat mesangial cells is PKC-NF-kappa B-dependent.
Park CW; Kim JH; Lee JH; Kim YS; Ahn HJ; Shin YS; Kim SY; Choi EJ; Chang YS; Bang BK
Diabetologia; 2000 Dec; 43(12):1544-53. PubMed ID: 11151765
[TBL] [Abstract][Full Text] [Related]
20. Nonenzymatic glycation of mesangial matrix and prolonged exposure of mesangial matrix to elevated glucose reduces collagen synthesis and proteoglycan charge.
Silbiger S; Crowley S; Shan Z; Brownlee M; Satriano J; Schlondorff D
Kidney Int; 1993 Apr; 43(4):853-64. PubMed ID: 8479121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
